Company Profile (AI Text)
Name: Tactogen
Canonical URL: https://wefunder.com/tactogen
Updated at: 2026-06-05T05:00:41Z

Tagline: Developing new MDMA-like medicines for effective prescription mental wellness.
Elevator pitch: Tactogen is a drug discovery and development organization making transformative medicines. Our focus for our first novel molecules is MDMA-like effects.

Key claims:
- Total raised on Wefunder: 92942 | citation: https://wefunder.com/tactogen#claim-total-raised
- Total investors: 158 | citation: https://wefunder.com/tactogen#claim-total-investors

Verified facts:
- Total raised on Wefunder: 92942 | observed_at: 2026-06-05T05:00:41Z | expires_at: 2026-06-06T05:00:41Z
- Total investors: 158 | observed_at: 2026-06-05T05:00:41Z | expires_at: 2026-06-06T05:00:41Z

Computed metrics:
- total_amount_raised: 92942
- total_investors: 158
- team_size: 7
- featured_investor_count: 1
- faq_count: 0
- recent_post_count: 0

Quick facts:
- Tactogen is a public benefit corporation making entactogen (MDMA-like) molecules. | citation: https://wefunder.com/tactogen#claim-fact-1
- CEO leverages 30+ years of experience in psychedelic preclinical and clinical research. | citation: https://wefunder.com/tactogen#claim-fact-2
- Many lead compounds ready for safety and toxicity studies. $2-4 million will complete that process. | citation: https://wefunder.com/tactogen#claim-fact-3
- Raised $6.3 million over 2.5 years from well known investors. | citation: https://wefunder.com/tactogen#claim-fact-4
- Significant potential to improve mental health treatment for millions of people. | citation: https://wefunder.com/tactogen#claim-fact-5